
Marsha M. Tsay
Examiner (ID: 10087, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1119 |
| Issued Applications | 471 |
| Pending Applications | 134 |
| Abandoned Applications | 540 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18210143
[patent_doc_number] => 20230056404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SYSTEMS AND METHODS FOR PROTEIN EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/839310
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839310 | SYSTEMS AND METHODS FOR PROTEIN EXPRESSION | Jun 12, 2022 | Pending |
Array
(
[id] => 18210143
[patent_doc_number] => 20230056404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SYSTEMS AND METHODS FOR PROTEIN EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/839310
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839310 | SYSTEMS AND METHODS FOR PROTEIN EXPRESSION | Jun 12, 2022 | Pending |
Array
(
[id] => 17867465
[patent_doc_number] => 20220290201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => MEDIUM COMPOSITION FOR CULTURING ANIMAL CELLS FOR PRODUCING RECOMBINANT EXTRACELLULAR MATRIX PROTEIN AND METHOD OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/829032
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829032 | MEDIUM COMPOSITION FOR CULTURING ANIMAL CELLS FOR PRODUCING RECOMBINANT EXTRACELLULAR MATRIX PROTEIN AND METHOD OF USING THE SAME | May 30, 2022 | Pending |
Array
(
[id] => 17960046
[patent_doc_number] => 20220340626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => PD-1 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/738484
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738484 | PD-1 homing endonuclease variants, compositions, and methods of use | May 5, 2022 | Issued |
Array
(
[id] => 17759265
[patent_doc_number] => 20220232877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Process for Isolating a High Purity Protein Preparation from Plant Material and Products Thereof
[patent_app_type] => utility
[patent_app_number] => 17/722893
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722893 | Process for Isolating a High Purity Protein Preparation from Plant Material and Products Thereof | Apr 17, 2022 | Abandoned |
Array
(
[id] => 19258003
[patent_doc_number] => 12018046
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications
[patent_app_type] => utility
[patent_app_number] => 17/718116
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12454
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17718116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/718116 | Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications | Apr 10, 2022 | Issued |
Array
(
[id] => 17776840
[patent_doc_number] => 20220243189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PROCOAGULANT COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/577684
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17577684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/577684 | PROCOAGULANT COMPOUNDS | Jan 17, 2022 | Abandoned |
Array
(
[id] => 18537856
[patent_doc_number] => 20230242959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MEDIUM COMPOSITION FOR CULTURING ANIMAL CELLS FOR PRODUCING RECOMBINANT EXTRACELLULAR MATRIX PROTEIN AND METHOD OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/781266
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781266 | MEDIUM COMPOSITION FOR CULTURING ANIMAL CELLS FOR PRODUCING RECOMBINANT EXTRACELLULAR MATRIX PROTEIN AND METHOD OF USING THE SAME | Dec 28, 2021 | Abandoned |
Array
(
[id] => 17688186
[patent_doc_number] => 20220195478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => System and Method for Improved Transient Protein Expression in CHO Cells
[patent_app_type] => utility
[patent_app_number] => 17/563665
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17563665
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/563665 | System and Method for Improved Transient Protein Expression in CHO Cells | Dec 27, 2021 | Abandoned |
Array
(
[id] => 17533861
[patent_doc_number] => 20220112470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => SYSTEMS AND METHODS FOR METABOLIC ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 17/556708
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556708 | SYSTEMS AND METHODS FOR METABOLIC ENGINEERING | Dec 19, 2021 | Pending |
Array
(
[id] => 17533861
[patent_doc_number] => 20220112470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => SYSTEMS AND METHODS FOR METABOLIC ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 17/556708
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556708 | SYSTEMS AND METHODS FOR METABOLIC ENGINEERING | Dec 19, 2021 | Pending |
Array
(
[id] => 19457691
[patent_doc_number] => 12098171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-24
[patent_title] => Hybrid sugar transporters with altered sugar transport activity and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/548410
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 11789
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548410 | Hybrid sugar transporters with altered sugar transport activity and uses thereof | Dec 9, 2021 | Issued |
Array
(
[id] => 18597564
[patent_doc_number] => 20230272360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 17/548124
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548124 | RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME | Dec 9, 2021 | Abandoned |
Array
(
[id] => 17655195
[patent_doc_number] => 20220175660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/546001
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546001 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | Dec 7, 2021 | Pending |
Array
(
[id] => 20093391
[patent_doc_number] => 20250223327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => MICROBIAL PRODUCTION OF TITIN FIBERS WITH EXCEPTIONAL MECHANICAL PERFORMANCE
[patent_app_type] => utility
[patent_app_number] => 18/036695
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036695
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036695 | MICROBIAL PRODUCTION OF TITIN FIBERS WITH EXCEPTIONAL MECHANICAL PERFORMANCE | Nov 14, 2021 | Pending |
Array
(
[id] => 17428714
[patent_doc_number] => 20220056422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => APPLICATION OF UTX GENE IN PREPARATION OF DRUGS FOR PREVENTING OR TREATING LIPID DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/513483
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513483 | APPLICATION OF UTX GENE IN PREPARATION OF DRUGS FOR PREVENTING OR TREATING LIPID DISEASES | Oct 27, 2021 | Abandoned |
Array
(
[id] => 18841690
[patent_doc_number] => 20230404093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => PROTEIN HAVING FERMENTED MILK VISCOSITY IMPROVING EFFECT, FERMENTED MILK USING THE SAME AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/031301
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031301
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031301 | PROTEIN HAVING FERMENTED MILK VISCOSITY IMPROVING EFFECT, FERMENTED MILK USING THE SAME AND METHOD FOR PRODUCING THE SAME | Oct 7, 2021 | Pending |
Array
(
[id] => 17579104
[patent_doc_number] => 20220135959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => CHIMERIC CLOTTING FACTORS
[patent_app_type] => utility
[patent_app_number] => 17/496092
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496092 | CHIMERIC CLOTTING FACTORS | Oct 6, 2021 | Abandoned |
Array
(
[id] => 20295233
[patent_doc_number] => 20250320476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-16
[patent_title] => A DNA Assembly Mix And Method Of Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/247616
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247616
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247616 | A DNA Assembly Mix And Method Of Uses Thereof | Sep 30, 2021 | Pending |
Array
(
[id] => 18299573
[patent_doc_number] => 20230109259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => STABILIZED PROTEIN IONIC LIQUID APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/491592
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491592 | STABILIZED PROTEIN IONIC LIQUID APPLICATIONS | Sep 30, 2021 | Pending |